相关实验视频
Updated: May 17, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.2K
在Teriparatide启动后,先前存在的大动脉狭窄的加速
Jayachidambaram Ambalavanan1, Carlos Hubbard2, Leila Zeinab Khan1
1Endocrinology and Metabolism, Cleveland Clinic, Cleveland, Ohio.
AACE clinical case reports
|August 5, 2024
概括
一位患有骨质疏松症的老年妇女接受特里巴拉提德治疗,与大动脉狭窄症的快速进展有关. 这一案例突出显示了特里巴拉提德与加速的膜化之间的潜在联系,需要仔细监测.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 老年病的医生 老年病的医生
背景情况:
- 特里巴拉提德是一种用于严重骨质疏松症的骨质代谢药物.
- 大动脉狭窄是一种常见的,老年人的渐进性膜状况.
相关概念视频
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

